Literature DB >> 16636012

Differential expression of inducible nitric oxide synthase and IL-12 between peritoneal and splenic macrophages stimulated with LPS plus IFN-gamma is associated with the activation of extracellular signal-related kinase.

Yi-Na Zhu1, Yi-Fu Yang, Shiro Ono, Xiang-Gen Zhong, Yong-Hong Feng, Yong-Xin Ren, Jia Ni, Yun-Feng Fu, Wei Tang, Jian-Ping Zuo.   

Abstract

Resident peritoneal macrophages (pMphi) are found deficient in T cell-stimulating capacity compared with the competent splenic macrophages (sMphi). Macrophages (Mphi)-derived nitric oxide (NO) and IL-12 have been shown to play crucial roles in the interaction between Mphi and T cells. To further understand differential functions between pMphi and sMphi, we focused on the production of NO and IL-12 from LPS plus IFN-gamma-activated Mphi. We demonstrated the differential expression of inducible nitric oxide synthase (iNOS) and IL-12 in pMphi and sMphi with LPS plus IFN-gamma stimulation. pMphi produced high level of NO but low level of IL-12, whereas sMphi produced high level of IL-12 but no NO. Furthermore, we demonstrated that there were no differences in IFN-gamma-induced signal transducer and activator of transcription-1 activation and consequent interferon regulatory factor-1 and interferon consensus sequence-binding protein up-regulation between pMphi and sMphi. Likewise, p38 mitogen-activated protein kinase was activated by LPS with identical kinetics in both pMphi and sMphi. However, LPS-induced extracellular signal-regulated kinase (ERK) activation was prolonged in pMphi comparing with sMphi. Moreover, we demonstrated, using inhibitor selective for ERK cascade (PD98059), that the prolonged ERK activation contributed a positive signal for iNOS expression and a negative signal for IL-12p40 expression in resident pMphi. In addition, anti-IL-10-neutralizing antibody plus indomethacin could abrogate the inhibitory effects of endogenous IL-10 and prostaglandin E2 on the production of IL-12 by resident pMphi possibly through suppressing ERK activation. Taken together, profound difference in ERK activation may account for differential LPS plus IFN-gamma responsiveness between pMphi and sMphi. High production of NO and low production of IL-12 by pMphi may contribute to its deficiency in T cell-stimulating capacity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16636012     DOI: 10.1093/intimm/dxl034

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  6 in total

1.  Strain differences in alveolar neutrophil infiltration and macrophage phenotypes in an acute lung inflammation model.

Authors:  Yinzhong Zhang; Xinchun Lin; Kiyokazu Koga; Koichiro Takahashi; Helena M Linge; Adriana Mello; Teresina Laragione; Percio S Gulko; Edmund J Miller
Journal:  Mol Med       Date:  2011-04-28       Impact factor: 6.354

2.  Development of the Antileishmanial Vaccine.

Authors:  Sunil Kumar; Shubhranshu Zutshi; Mukesh Kumar Jha; Prashant Chauhan; Bhaskar Saha
Journal:  Methods Mol Biol       Date:  2022

3.  M2 polarization of murine peritoneal macrophages induces regulatory cytokine production and suppresses T-cell proliferation.

Authors:  Shinji Oishi; Ryosuke Takano; Satoshi Tamura; Shinya Tani; Moriya Iwaizumi; Yasushi Hamaya; Kosuke Takagaki; Toshi Nagata; Shintaro Seto; Toshinobu Horii; Satoshi Osawa; Takahisa Furuta; Hiroaki Miyajima; Ken Sugimoto
Journal:  Immunology       Date:  2016-08-09       Impact factor: 7.397

4.  Arginase Isoform Expression in Chronic Rhinosinusitis.

Authors:  Diana Vlad; Silviu Albu
Journal:  J Clin Med       Date:  2019-11-01       Impact factor: 4.241

5.  Characterization of murine macrophages from bone marrow, spleen and peritoneum.

Authors:  Changqi Wang; Xiao Yu; Qi Cao; Ya Wang; Guoping Zheng; Thian Kui Tan; Hong Zhao; Ye Zhao; Yiping Wang; David Ch Harris
Journal:  BMC Immunol       Date:  2013-02-05       Impact factor: 3.615

6.  Gastrin inhibits gastric cancer progression through activating the ERK-P65-miR23a/27a/24 axis.

Authors:  Li-Dong Zu; Xing-Chun Peng; Zhi Zeng; Jing-Long Wang; Li-Li Meng; Wei-Wei Shen; Chun-Ting Hu; Ye Yang; Guo-Hui Fu
Journal:  J Exp Clin Cancer Res       Date:  2018-06-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.